Further studies are needed to determine whether K2-18b, which orbits a star 120 light-years away, is inhabited, or even ...

During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...

Simcere Zaiming Pharmaceutical Co. Ltd. has received clinical trial approval from China’s National Medical Products Administration (NMPA) for the company’s antibody-drug conjugate (ADC), SIM-0686, for ...

Elon Musk's organization aims to save $1 million annually by converting government records to digital formats. That switch ...

In a high-stakes standoff, President Donald Trump’s administration says it will freeze $2.2 billion in federal research ...

University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

今日，迈威生物宣布与深势科技达成战略合作。双方将充分发挥各自在生物药研发和人工智能（AI）大模型领域的优势，共同打造生物药研发大模型平台。而就在不久前，迈威生物宣布与英矽智能达成战略合作，基于双方各自在ADC研发和人工智能（AI）领域的技术优势，以AI赋能ADC创新药研发。

The evolution of application delivery controllers (ADCs) is inextricably tied to how applications have changed over time.

Landfill compactors are at their peak productivity when traveling at full speed—even if it’s only 3 miles per hour. But at the end of every run, that machine must slow down, stop, reverse direction ...

ONA-255 is a first-in-class molecule aimed at a new ADC target found in numerous common solid tumours. The collaboration is centred around Reveal Genomics’ chief scientific offi ...